Literature DB >> 12777074

Secretory meningiomas.

Nagihan Colakoğlu1, Eren Demirtaş, Nezih Oktar, Nilgün Yüntem, Sertaç Islekel, Nurcan Ozdamar.   

Abstract

Secretory meningiomas are a rare meningioma subtype. Among meningiomas, the frequency of secretory meningiomas is 1.6%. Unlike other meningioma types, most of the patients were female (ratio 3:1). No recurrence was reported during the 24-180 months follow-up period of our secretory meningiomas in which, a low level of 0.3% Ki-67 proliferative index was reported. In this meningioma subtype, the percentage of cases with positive progesterone receptor is 33%. With carcinoembryonic antigen, cytokeratin and epithelial membrane antigen, in all the cases positivity was observed in both, the inclusions and the cells surrounding them. With human milk fat globulin 2, a high ratio (92%) of positivity was observed. Majority of the cases were negative with CA125, only three of the cases had suspicious positivity. Distribution of inclusions was irregular and their positive reactions showed varying staining features. Positivity with alpha-1-antitripsin was seen not only in the inclusions but also in some meningothelial cells as well. Ubiquitin was positive in inclusions of the 83% of cases. Staining features of the inclusions pointed out the possibility of them being in a varying age and/or content. Secretory meningiomas are a different type compared to other meningiomas, not only with their histological features but also with their clinical features as well.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777074     DOI: 10.1023/a:1023319407645

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  33 in total

1.  Secretory meningioma.

Authors:  G C Ejeckam; B Azadeh; A Hamad
Journal:  Histopathology       Date:  1992-11       Impact factor: 5.087

2.  [Ultrastructural study of meningiothelial meningioma with 'hyaline inclusions' (author's transl)].

Authors:  M Berard; M F Tripier; R Choux; M A Chrestian; J Hassoun; M Toga
Journal:  Acta Neuropathol       Date:  1978-04-26       Impact factor: 17.088

3.  Cytologic features of secretory meningioma.

Authors:  D R Hinton; K Kovacs; P T Chandrasoma
Journal:  Acta Cytol       Date:  1999 Mar-Apr       Impact factor: 2.319

Review 4.  Secretory meningioma with elevated serum carcinoembryonic antigen level.

Authors:  S Tsunoda; T Takeshima; T Sakaki; T Morimoto; T Hoshida; Y Watabe; K Goda
Journal:  Surg Neurol       Date:  1992-05

5.  Progesterone and estrogen receptors in meningiomas: prognostic considerations.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

6.  Meningiomas with a non-meningotheliomatous component. A new type of tumour?

Authors:  K F Kock; P S Teglbjaerg
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

7.  The vascular component in meningiomas associated with severe cerebral edema.

Authors:  V R Challa; D M Moody; R B Marshall; D L Kelly
Journal:  Neurosurgery       Date:  1980-10       Impact factor: 4.654

8.  Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features.

Authors:  A Brandis; S Mirzai; M Tatagiba; G F Walter; M Samii; H Ostertag
Journal:  Neurosurgery       Date:  1993-08       Impact factor: 4.654

9.  The fine structure of hyaline inclusions (pseudopsammoma bodies) in meningiomas.

Authors:  J J Kepes
Journal:  J Neuropathol Exp Neurol       Date:  1975-05       Impact factor: 3.685

10.  The fine structure of hyaline inclusions in meningioma.

Authors:  T Kubota; A Hirano; S Yamamoto
Journal:  J Neuropathol Exp Neurol       Date:  1982-01       Impact factor: 3.685

View more
  6 in total

1.  Clinical features, surgical management, and prognostic factors of secretory meningiomas: a single-center case series of 149 patients.

Authors:  Xiaogang Tao; Kun Wang; Jinqian Dong; Zonggang Hou; Zhen Wu; Junting Zhang; Baiyun Liu
Journal:  J Neurooncol       Date:  2017-11-15       Impact factor: 4.130

2.  Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration.

Authors:  Wuttipong Tirakotai; Hans-Dieter Mennel; Ilhan Celik; Dieter Hellwig; Helmut Bertalanffy; Thomas Riegel
Journal:  Neurosurg Rev       Date:  2005-07-12       Impact factor: 3.042

3.  Secretory meningiomas: clinical, radiological and pathological findings in 70 consecutive cases at one institution.

Authors:  Dai-Jun Wang; Qing Xie; Ye Gong; Yin Wang; Hai-Xia Cheng; Ying Mao; Ping Zhong; Feng-Ping Huang; Kang Zheng; Yong-Fei Wang; Wei-Min Bao; Bo-Jie Yang; Hong Chen; Li-Qian Xie; Ming-Zhe Zheng; Hai-Liang Tang; Hong-Da Zhu; Xian-Cheng Chen; Liang-Fu Zhou
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

4.  Secretory meningiomas: a benign subgroup causing life-threatening complications.

Authors:  Jan Regelsberger; Christian Hagel; Pedram Emami; Thorsten Ries; Oliver Heese; Manfred Westphal
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

5.  Neurosurgery in an octogenarian with dementia.

Authors:  Gemma Andrew; Estelle Healy; Brian Herron; Stephen Cooke; A Peter Passmore; Stephen Todd
Journal:  Ulster Med J       Date:  2011-01

6.  Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence.

Authors:  B R Ongaratti; C B O Silva; G Trott; T Haag; C G S Leães; N P Ferreira; M C Oliveira; J F S Pereira-Lima
Journal:  Braz J Med Biol Res       Date:  2016-03-18       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.